News Industry News Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset October 13, 2015
News Conference News TCT 2015 Discussion Highlights Merits, Limitations of Small Trials Yael L. Maxwell October 13, 2015
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015
News Daily News Un Estudio Asegura que Muchos Ingresos en la UCI de Pacientes IAM son Innecesarios Todd Neale September 28, 2015
News Daily News Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary Todd Neale September 28, 2015
News Daily News Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy L.A. McKeown September 21, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Conference News ESC 2015 Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI Yael L. Maxwell August 31, 2015
News Daily News Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence Leah Lawrence August 30, 2015
News Conference News ESC 2015 BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis Yael L. Maxwell August 30, 2015
News Daily News Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease L.A. McKeown August 12, 2015
News Daily News Cardiac Rehab After Acute MI Still Underutilized in Older Patients Yael L. Maxwell August 07, 2015
News Daily News Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib August 04, 2015
News Daily News COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men L.A. McKeown August 03, 2015
News Daily News RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years July 30, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015